Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS) is a chronic skin condition characterized by painful lumps, abscesses, and scarring, typically occurring in areas where skin rubs together, such as the armpits and groin.
Hidradenitis Suppurativa: Upadacitinib Study
We are testing Upadacitinib in adults and adolescents with moderate to severe Hidradenitis Suppurativa who haven't responded to other treatments. The goal is to see if it is more effective and safe than a placebo.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 12 years old?
- Do you weigh at least 30 kg (66 lbs)?
- Have you been diagnosed with hidradenitis suppurativa (HS) for at least 6 months?
- Have you used a TNF inhibitor or a nonanti-TNF biologic therapy for HS for at least 12 weeks?
- Do you have HS lesions in at least 2 different areas of your body?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Upadacitinib
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medical University Of Graz
Universitaetsklinik fuer Dermatologie und Venerologie
Graz, Austria
Medical University Of Vienna
Universitaetsklinik fuer Dermatologie
Vienna, Austria
Grand Hopital De Charleroi
Dermatology Department
Châtelet, Belgium
Sponsor: Abbvie Deutschland GmbH & Co. KG
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.